These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 11871013)

  • 1. [Use of maxipime in treating infections in neutropenic patients].
    Ptushkin VV
    Antibiot Khimioter; 2001; 46(9):30-2. PubMed ID: 11871013
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience in using the fourth generation cephalosporin cefepime (maxipime) in treating Russian patients with severe infections].
    Fomina IP
    Antibiot Khimioter; 2001; 46(9):45-7. PubMed ID: 11871017
    [No Abstract]   [Full Text] [Related]  

  • 3. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors.
    Oguz A; Karadeniz C; Citak EC; Cil V; Eldes N
    Pediatr Hematol Oncol; 2006; 23(3):245-53. PubMed ID: 16517540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bacterial infections in neutropenic patients with cancer].
    Matysiak M
    Przegl Lek; 2003; 60 Suppl 5():54-7. PubMed ID: 14575008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison.
    Corapcioglu F; Sarper N; Zengin E
    Pediatr Hematol Oncol; 2006; 23(3):177-86. PubMed ID: 16517534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cefepime (maxipime) in the treatment of abdominal surgical infections].
    Gel'fand BR; Mamontova OA; Gel'fand EB; Tsydenzhapov ETs; Brazhnk GB
    Antibiot Khimioter; 2001; 46(2):22-5. PubMed ID: 11544747
    [No Abstract]   [Full Text] [Related]  

  • 7. [A fourth generation cephalosporin--cefepime (maxipime) in pediatrics].
    Beloborodova NV
    Antibiot Khimioter; 2001; 46(9):19-25. PubMed ID: 11871011
    [No Abstract]   [Full Text] [Related]  

  • 8. Empirical therapy of infections in neutropenic patients.
    Gaya H
    Br J Haematol; 1998 May; 101 Suppl 1():5-9. PubMed ID: 9607734
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotic choice in the neutropenic patient.
    Winslow DL
    Del Med J; 1984 Jul; 56(7):413-5. PubMed ID: 6479386
    [No Abstract]   [Full Text] [Related]  

  • 10. Cefepime (Maxipime)--a new parenteral cephalosporin.
    Med Lett Drugs Ther; 1996 Sep; 38(983):84-6. PubMed ID: 8804383
    [No Abstract]   [Full Text] [Related]  

  • 11. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever.
    Kalman D; Barriere SL
    J Infect Dis; 1991 Jan; 163(1):201-3. PubMed ID: 1984470
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment and reporting of clinical trials of empirical therapy in neutropenic patients.
    Donnelly JP
    J Antimicrob Chemother; 1991 Mar; 27(3):377-87. PubMed ID: 2037542
    [No Abstract]   [Full Text] [Related]  

  • 13. [Infections in neutropenic patients].
    Berenguer J
    Enferm Infecc Microbiol Clin; 1995 Feb; 13(2):113-20. PubMed ID: 7711117
    [No Abstract]   [Full Text] [Related]  

  • 14. A retrospective study of infections in neutropenic patients.
    Madiajagane R
    J Indian Med Assoc; 1998 Aug; 96(8):239-40, 244. PubMed ID: 9830290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of bacterial infections in haematological patients.
    Galea G
    Br J Hosp Med; 1982 Jul; 28(1):74, 76, 79 passim. PubMed ID: 6289951
    [No Abstract]   [Full Text] [Related]  

  • 16. Update on infections in neutropenic hosts.
    Gulick PG
    J Am Osteopath Assoc; 1990 Oct; 90(10):920-5. PubMed ID: 2279965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of infections in immunocompromised cancer patients.
    Bajetta E; Gasparini G; Monfardini S; Volonterio A; Buzzoni R; Shinde S
    Haematologica; 1984; 69(5):576-97. PubMed ID: 6437936
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
    Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of cefepime versus ticarcilline/clavulanate as empirical treatment of febrile neutropenia in lymphoma patients.
    Naseem A; Hussain Y; Ahmad B; Aziz MT; Ahmad M; Hameed H
    J Pak Med Assoc; 2011 Jan; 61(1):18-22. PubMed ID: 22368896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of intravenous ceftazidime in childhood infections].
    Kanra G; Gürsavaş M; Aydin M; Cengizlier R; Seçmeer G; Ceyhan M
    Mikrobiyol Bul; 1990 Jul; 24(3):226-36. PubMed ID: 2283973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.